JSP
ABMD

Jackson Square Partners’s Abiomed Inc ABMD Stock Holding History

Jackson Square Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-428,103
Closed -$105M – 93
2022
Q3 		$105M Sell
428,103
-32,434
-7% -$8.76M 2.76% 15
2022
Q2 		$114M Buy
460,537
+404
+0.1% +$109K 2.66% 14
2022
Q1 		$152M Buy
460,133
+21,045
+5% +$6.48M 1.51% 27
2021
Q4 		$158M Sell
439,088
-4,107
-0.9% -$1.39M 1.33% 30
2021
Q3 		$144M Sell
443,195
-5,909
-1% -$2M 0.91% 46
2021
Q2 		$140M Sell
449,104
-124,975
-22% -$38.3M 0.8% 53
2021
Q1 		$183M Sell
574,079
-8,234
-1% -$2.64M 1.04% 39
2020
Q4 		$189M Sell
582,313
-17,391
-3% -$4.81M 0.75% 47
2020
Q3 		$166M Sell
599,704
-14,245
-2% -$4.1M 0.78% 41
2020
Q2 		$148M Buy
613,949
+221,811
+57% +$44.5M 0.74% 42
2020
Q1 		$56.9M Buy
392,138
+133,098
+51% +$22.1M 0.36% 67
2019
Q4 		$44.2M Buy
+259,040
New +$48M 0.23% 71
2019
Q2 		– Sell
-5,694
Closed -$1.63M – 86
2019
Q1 		$1.63M Sell
5,694
-139,845
-96% -$46.5M 0.01% 77
2018
Q4 		$47.3M Sell
145,539
-94,621
-39% -$32.9M 0.29% 68
2018
Q3 		$108M Sell
240,160
-27,798
-10% -$11M 0.55% 41
2018
Q2 		$110M Sell
267,958
-253,258
-49% -$91.8M 0.56% 40
2018
Q1 		$152M Sell
521,216
-46,992
-8% -$11.9M 0.76% 33
2017
Q4 		$106M Buy
568,208
+23,101
+4% +$4.31M 0.54% 39
2017
Q3 		$91.9M Buy
545,107
+17,083
+3% +$2.58M 0.45% 46
2017
Q2 		$75.7M Sell
528,024
-195,639
-27% -$26.3M 0.39% 54
2017
Q1 		$90.6M Buy
723,663
+14,939
+2% +$1.73M 0.45% 54
2016
Q4 		$79.9M Buy
708,724
+39,951
+6% +$4.63M 0.41% 53
2016
Q3 		$86M Sell
668,773
-569,880
-46% -$68.3M 0.39% 51
2016
Q2 		$135M Sell
1,238,653
-481,827
-28% -$47.9M 0.57% 43
2016
Q1 		$163M Sell
1,720,480
-103,423
-6% -$8.73M 0.65% 40
2015
Q4 		$165M Buy
1,823,903
+162,571
+10% +$13.8M 0.61% 40
2015
Q3 		$154M Sell
1,661,332
-167,652
-9% -$14.8M 0.7% 38
2015
Q2 		$120M Sell
1,828,984
-66,853
-4% -$4.44M 0.46% 48
2015
Q1 		$136M Sell
1,895,837
-1,128,922
-37% -$61.3M 0.52% 48
2014
Q4 		$115M Sell
3,024,759
-1,723,300
-36% -$54.4M 0.45% 44
2014
Q3 		$118M Buy
4,748,059
+28,460
+0.6% +$721K 0.5% 43
2014
Q2 		$119M Buy
+4,719,599
New +$110M 0.46% 45

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jackson Square Partners's ABMD Position: Q4 2022 in Review

Jackson Square Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 428,103 shares — an estimated $105M sold.

Jackson Square Partners first reported a position in ABMD in Q2 2014 and held it in 32 quarters. The position peaked at $189M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Jackson Square Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Jackson Square Partners sold 428,103 Abiomed Inc shares in Q4 2022, an estimated $105M.
  • Jackson Square Partners first reported a position in Abiomed Inc in Q2 2014 and held it in 32 quarters.
  • Jackson Square Partners's Abiomed Inc position peaked at $189M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Jackson Square Partners's 13F filing for Q4 2022, filed 9 Feb 2023.